Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research

New functional probiotic Lactobacillus sakei probio 65 alleviates atopic symptoms in the mouse.

  • 2008-09
  • Journal of Medicinal Food 11(3)
    • C. Park
    • M. Youn
    • Young-mi Jung
    • Hong-Joong Kim
    • Y. Jeong
    • Han-Ki Lee
    • H. Kim
    • I. Lee
    • Soo Won Lee
    • K. Kang
    • Yong-Ha Park

Study Design

Type
Clinical Trial
Population
Mice with allergen-induced dermatitis
Methods
In vivo experiment with mice.
  • Animal Study

Abstract

The purpose of this study was to investigate the improvement of allergic dermatitis in chemical allergen-induced mice by Lactobacillus sakei probio 65. L. sakei probio-65 was isolated from kimchi, a traditional Korean fermented food. This strain was resistant to gastric acidity, bile, and several antibiotics and possessed antimicrobial activity against several pathogenic microorganisms. To investigate whether the probiotic activity of L. sakei probio 65 was effective for treating allergic dermatitis, the organism was supplied to mice triggered by allergen (1-chloro-2,4-dinitrobenzene). Mice that received L. sakei probio 65 showed a more rapid recovery compared to control mice, as assessed by visual evaluation of the severity of allergic dermatitis and levels of immunoglobulin (Ig) E and interleukin (IL)-4. L. sakei probio 65 exhibited good probiotic properties in vitro and in mice and was effective in reducing allergen-induced skin inflammation through the regulation of both elevated IgE and IL-4 in sensitized mice.

Research Insights

    Back to top